NEW YORK, Jan. 9 (GenomeWeb News) - Inproteo said today it has licensed a patent for a protein purification technique to ZymoGenetics.
ZymoGenetics' license to the so-called Smith patent, which protects the His tag fusion protein purification technique, covers all uses of the technology for the life of the patent.
Inproteo, formerly known as the Indiana Proteomics Consortium - a partnership between Indiana University, Purdue University, and Eli Lilly - recently obtained a license to the patent, U.S. Patent No. 4,569,794, from Eli Lilly. It holds the exclusive right to sublicense the patent and has already licensed it to a number of companies.